Abstract:Phosphorylation of tau at Ser (396, 404) (p-tau396,404) is one of the earliest phosphorylation events, and plasma p-tau396,404 level appears to be a potentially promising biomarker of Alzheimer's disease (AD). The low abundance and easy degradation of p-tau in the plasma make the lateral flow assay (LFA) a suitable choice for point-of-care detection of plasma p-tau396,404 levels. Herein, based on our screening of a pair of p-tau396,404-specific antibodies, we developed a colorimetric and surface-enhanced Raman scattering (SERS) dual-readout LFA for the rapid, highly sensitive, and robust detection of plasma p-tau396,404 levels. This LFA realized a detection limit of 60 pg/mL by the naked eye or 3.8 pg/mL by SERS without cross-reacting with other tau species. More importantly, LFA rapidly and accurately differentiated AD patients from healthy controls, suggesting that it has the potential for clinical point-of-care application in AD diagnosis. This dual-readout LFA has the advantages of simple operation, rapid, and ultra-sensitive detection, providing a new way for early AD diagnosis and intervention, especially in primary and community AD screening. Electronic supplementary material: Supplementary material (characterization of AuNPs and 4-MBA@AuNP probe; the optimal 4-MBA load for AuNPs; the optimal K2CO3 volumes for 4-MBA@AuNP-3G5 conjugates; the optimal 3G5 load for 4-MBA@AuNP conjugates; effect of NaCl concentration on 4-MBA@AuNP-3G5 stability; the linear curve of T-line color and SERS intensity versus different p-tau396,404 concentrations; the comparison of colorimetric-based LFA test results and the diagnosis results; Raman intensities and antibody activity of 4-MBA@AuNP-3G5 before and after storage; colorimetric intensity of dual-readout LFA detecting different concentrations of p-tau396,404 protein; sequence of synthesized peptides used in this study; information of the participants in this study; the information of antibodies used in this study) is available in the online version of this article at 10.1007/s12274-022-5354-4.

Recognition of Tau Protein Glycation with a Tailored Aerolysin Nanopore

T232K/K238Q Aerolysin Nanopore for Mapping Adjacent Phosphorylation Sites of a Single Tau Peptide

Enhanced Identification of Tau Acetylation and Phosphorylation with an Engineered Aerolysin Nanopore

DNAzyme-driven tripedal DNA walker triggered hybridization chain reaction for label-free electrochemical detection of Alzheimer's tau protein

Precise Structural Analysis of Neutral Glycans Using Aerolysin Mutant T240R Nanopore.

Orientation Identification of Peptide Translocation Through an Aerolysin Nanopore

Boosting the sensitivity for tau protein detection with a bifunctional nanoenzyme signal amplifier

A Tauopathy-Homing and Autophagy-Activating Nanoassembly for Specific Clearance of Pathogenic Tau in Alzheimer's Disease.

Identification of tagged glycans with a protein nanopore

Ultrasensitive and point-of-care detection of plasma phosphorylated tau in Alzheimer's disease using colorimetric and surface-enhanced Raman scattering dual-readout lateral flow assay

The Analysis of Single Cysteine Molecules with an Aerolysin Nanopore

The Charge-Sensitive Aerolysin Nanopore For Direct Measuring Phosphorylation/Dephosphorylation

Identification of Essential Sensitive Regions of the Aerolysin Nanopore for Single Oligonucleotide Analysis

Deep Learning-Assisted Single-Molecule Detection of Protein Post-translational Modifications with a Biological Nanopore

Real-Time Monitoring Conformational Changes of a Intrinsically Disordered Protein with Aerolysin Nanopore

Live-cell visualization of tau aggregation in human neurons

Glycated Tau-Protein in Alzheimer-Disease - A Mechanism for Induction of Oxidant Stress

Diversified Exploitation of Aerolysin Nanopore in Single-Molecule Sensing and Protein Sequencing

Detection of Peptides with Different Charges and Lengths by Using the Aerolysin Nanopore

In-situ nanozyme catalytic amplification coupled with a universal antibody orientation strategy based electrochemical immunosensor for AD-related biomarker

Capturing the Conformational Heterogeneity of the Β-Amyloid Peptide Sequence Using the Engineered Aerolysin Confinement